当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Pantea Nabian
Introduction: This study examined how well group cognitive behavioral therapy treated anxiety and depressive symptoms in Parkinson's disease patients.
Methods: The experimental and control groups participated in this quasi-experimental study's pretest, posttest, and follow-up phases. Patients aged 60 to 75 from psychiatric and Parkinson's disease centers made up the study population. A random sample of 90 people who scored highly on the Beck Depression Scale and Beck Anxiety Inventory was divided into two 45 groups at random: experimental and control groups. The experimental group underwent group cognitive behavioral therapy for eight weeks, once a week; there was no training for the control group. Methods of analysis of variance with repeated measures were employed to test the hypotheses.
Results: The outcomes demonstrated that the independent variable is successful in reducing symptoms of anxiety and depression. Patients with Parkinson's disease saw reduced anxiety and depression because to group cognitive behavioral therapy.
Conclusion: Effective psychological therapies, including group cognitive behavioral therapy, can improve mood, lessen anxiety and despair, and help patients more closely follow treatment guidelines. Thus, they can take effective measures to improve the physical and mental health of these patients and aid in the prevention of Parkinson's problems.